Skip to main content
. 2018 Nov 26;18:88. doi: 10.1186/s12902-018-0315-6

Table 1.

Major clinical manifestations of Alström syndrome and corresponding pre-clinical effects of PBI-4050

Clinical features of ALMS Corresponding pre-clinical effects of PBI-4050
Loss of organ function due to fibrosis involving
 Heart ↓ heart fibrosis in suprarenal aortic banding in rats
 Lung ↓ lung fibrosis in bleomycin-induced lung fibrosis in mice
 Liver ↓ liver fibrosis in CCl4-induced liver fibrosis in rats
 Kidneys (renal failure) ↓ kidney fibrosis in various animal models of kidney fibrosis
Type 2 diabetes mellitus
 Early hyperinsulinemia Reduces insulin resistance in db/db diabetic mice and db/db eNOS−/− diabetic mice
 Severe insulin resistance Normalizes glycaemia in diabetic mice
 Late pancreatic failure Maintains (early treatment) or restores (late treatment) insulin content in pancreatic islets

eNOS−/− endothelial nitric oxide synthase knockout (mice)